TEMSIROLIMUS
Clinical safety rating: avoid
Contraindicated (not allowed)
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Solution 25 mg/mL - Intravenous
Clinical note
Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperglycemia and interstitial lung disease.
asthenia
Loading safety data…